Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCR2, also known as Interleukin 8 receptor beta (IL8RB), is a member of the G protein-coupled receptor (GPCR) family and functions primarily as a chemokine receptor. It plays key roles in immune response and inflammation, mediating neutrophil migration and angiogenesis. Dysregulation has been implicated in various diseases including autoimmune disorders, chronic inflammatory conditions, cancer, and atherosclerosis.
Antibodies against CXCR2 can inhibit neutrophil recruitment/inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 8 Receptor Beta (CXCR2).